BeatMove device: could music be the key to better walking rehab?
NCT ID NCT06226844
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether music therapy delivered by the BeatMove device can help people with leg artery disease walk farther during a 3-month outpatient walking program. Fifty-four participants will either get real music therapy or a sham version while doing 36 walking sessions. The main goal is to see if music boosts walking distance and helps patients stick with their rehab.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- music therapy (BeatMove device)
- What this could lead to
- If it works, this could offer a simple, enjoyable way to help people with leg artery disease walk farther and stick with their rehab.
- What could go wrong
- This is a small, early-stage trial with only 54 participants. The music therapy may not improve walking distance more than the sham version, and results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nîmes
RECRUITINGNîmes, 30029, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.